

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glycolipid catabolic process (GO:0019377) | 8.31108139 |
| 2 | L-ascorbic acid metabolic process (GO:0019852) | 7.84715945 |
| 3 | renal absorption (GO:0070293) | 7.79576687 |
| 4 | one-carbon compound transport (GO:0019755) | 7.65874313 |
| 5 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 7.34219841 |
| 6 | membrane lipid catabolic process (GO:0046466) | 7.29127666 |
| 7 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 7.15228392 |
| 8 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 7.04263119 |
| 9 | xenobiotic catabolic process (GO:0042178) | 6.90852840 |
| 10 | icosanoid secretion (GO:0032309) | 6.90259505 |
| 11 | arachidonic acid secretion (GO:0050482) | 6.90259505 |
| 12 | neutrophil mediated immunity (GO:0002446) | 6.86783952 |
| 13 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.32522870 |
| 14 | protein retention in ER lumen (GO:0006621) | 6.04888818 |
| 15 | glutathione derivative metabolic process (GO:1901685) | 5.89286096 |
| 16 | glutathione derivative biosynthetic process (GO:1901687) | 5.89286096 |
| 17 | icosanoid transport (GO:0071715) | 5.86844822 |
| 18 | fatty acid derivative transport (GO:1901571) | 5.86844822 |
| 19 | ceramide catabolic process (GO:0046514) | 5.72236012 |
| 20 | daunorubicin metabolic process (GO:0044597) | 5.70889176 |
| 21 | polyketide metabolic process (GO:0030638) | 5.70889176 |
| 22 | doxorubicin metabolic process (GO:0044598) | 5.70889176 |
| 23 | regulation of skeletal muscle contraction (GO:0014819) | 5.59746290 |
| 24 | tetrapyrrole metabolic process (GO:0033013) | 5.48444538 |
| 25 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.45791783 |
| 26 | peptidyl-proline hydroxylation (GO:0019511) | 5.29483255 |
| 27 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 5.22394103 |
| 28 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.18121481 |
| 29 | leukotriene biosynthetic process (GO:0019370) | 5.12826226 |
| 30 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.12432180 |
| 31 | lung lobe morphogenesis (GO:0060463) | 5.11193683 |
| 32 | surfactant homeostasis (GO:0043129) | 5.08577438 |
| 33 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 5.05093738 |
| 34 | myeloid leukocyte mediated immunity (GO:0002444) | 4.95025482 |
| 35 | gas transport (GO:0015669) | 4.92984179 |
| 36 | antibacterial humoral response (GO:0019731) | 4.92278044 |
| 37 | intestinal epithelial cell development (GO:0060576) | 4.87986330 |
| 38 | antimicrobial humoral response (GO:0019730) | 4.85110204 |
| 39 | detection of other organism (GO:0098543) | 4.70631593 |
| 40 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 4.68429295 |
| 41 | regulation of guanylate cyclase activity (GO:0031282) | 4.68323970 |
| 42 | phosphatidylserine metabolic process (GO:0006658) | 4.65007093 |
| 43 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 4.61703088 |
| 44 | interferon-gamma secretion (GO:0072643) | 4.58748810 |
| 45 | retinol metabolic process (GO:0042572) | 4.58694038 |
| 46 | retinoic acid metabolic process (GO:0042573) | 4.44361472 |
| 47 | negative regulation of humoral immune response (GO:0002921) | 4.42627722 |
| 48 | negative regulation of complement activation (GO:0045916) | 4.42376886 |
| 49 | sterol catabolic process (GO:0016127) | 4.41664327 |
| 50 | cholesterol catabolic process (GO:0006707) | 4.41664327 |
| 51 | leukotriene metabolic process (GO:0006691) | 4.37281820 |
| 52 | response to nitrosative stress (GO:0051409) | 4.36801483 |
| 53 | multicellular organismal water homeostasis (GO:0050891) | 4.36671847 |
| 54 | phosphatidic acid biosynthetic process (GO:0006654) | 4.28398901 |
| 55 | phosphatidic acid metabolic process (GO:0046473) | 4.28398901 |
| 56 | regulation of cellular extravasation (GO:0002691) | 4.24406398 |
| 57 | O-glycan processing (GO:0016266) | 4.23936991 |
| 58 | sphingolipid catabolic process (GO:0030149) | 4.21963247 |
| 59 | detection of bacterium (GO:0016045) | 4.20081905 |
| 60 | regulation of triglyceride catabolic process (GO:0010896) | 4.14964176 |
| 61 | cellular response to arsenic-containing substance (GO:0071243) | 4.13695648 |
| 62 | water-soluble vitamin metabolic process (GO:0006767) | 4.13566379 |
| 63 | cardiovascular system development (GO:0072358) | 4.09020856 |
| 64 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.07520023 |
| 65 | cellular protein catabolic process (GO:0044257) | 4.06475982 |
| 66 | vitamin transmembrane transport (GO:0035461) | 4.06404182 |
| 67 | protein hydroxylation (GO:0018126) | 4.03920998 |
| 68 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.95213157 |
| 69 | chemical homeostasis within a tissue (GO:0048875) | 3.95147123 |
| 70 | alditol phosphate metabolic process (GO:0052646) | 3.94589230 |
| 71 | flavonoid metabolic process (GO:0009812) | 3.88352172 |
| 72 | sterol transport (GO:0015918) | 3.81617782 |
| 73 | cholesterol transport (GO:0030301) | 3.81617782 |
| 74 | sulfur amino acid catabolic process (GO:0000098) | 3.78567633 |
| 75 | positive regulation of osteoblast proliferation (GO:0033690) | 3.76335231 |
| 76 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.76144419 |
| 77 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.75724584 |
| 78 | water homeostasis (GO:0030104) | 3.74664812 |
| 79 | cellular response to cadmium ion (GO:0071276) | 3.73702084 |
| 80 | hemidesmosome assembly (GO:0031581) | 3.70565859 |
| 81 | negative regulation of protein activation cascade (GO:2000258) | 3.69681326 |
| 82 | primary alcohol metabolic process (GO:0034308) | 3.69507688 |
| 83 | angiotensin maturation (GO:0002003) | 3.66807805 |
| 84 | phospholipid catabolic process (GO:0009395) | 3.64053571 |
| 85 | regulation of cholesterol homeostasis (GO:2000188) | 3.62568349 |
| 86 | glycoside metabolic process (GO:0016137) | 3.53331293 |
| 87 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.51200192 |
| 88 | * negative regulation of epidermal cell differentiation (GO:0045605) | 3.49334213 |
| 89 | cellular response to zinc ion (GO:0071294) | 3.48830135 |
| 90 | hormone catabolic process (GO:0042447) | 3.41646322 |
| 91 | regulation of acrosome reaction (GO:0060046) | 3.40117776 |
| 92 | vitamin metabolic process (GO:0006766) | 3.39734032 |
| 93 | extracellular regulation of signal transduction (GO:1900115) | 3.38842285 |
| 94 | extracellular negative regulation of signal transduction (GO:1900116) | 3.38842285 |
| 95 | intestinal cholesterol absorption (GO:0030299) | 3.37089247 |
| 96 | positive regulation of steroid biosynthetic process (GO:0010893) | 3.29385888 |
| 97 | phosphatidylglycerol metabolic process (GO:0046471) | 3.28507122 |
| 98 | toxin metabolic process (GO:0009404) | 3.28306676 |
| 99 | positive regulation of pseudopodium assembly (GO:0031274) | 3.27064461 |
| 100 | face development (GO:0060324) | 3.26178678 |
| 101 | regulation of cardioblast proliferation (GO:0003264) | 3.25192487 |
| 102 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.25192487 |
| 103 | regulation of female gonad development (GO:2000194) | 3.23286236 |
| 104 | retinoid metabolic process (GO:0001523) | 3.19808864 |
| 105 | regulation of bile acid biosynthetic process (GO:0070857) | 3.17775493 |
| 106 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.17413182 |
| 107 | desmosome organization (GO:0002934) | 3.17195678 |
| 108 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.16896800 |
| 109 | xenobiotic metabolic process (GO:0006805) | 3.14944398 |
| 110 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.14507268 |
| 111 | multicellular organismal catabolic process (GO:0044243) | 3.12976716 |
| 112 | peptide catabolic process (GO:0043171) | 3.10899763 |
| 113 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 3.09846810 |
| 114 | glandular epithelial cell differentiation (GO:0002067) | 3.09610574 |
| 115 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.09001839 |
| 116 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.05904394 |
| 117 | aldehyde catabolic process (GO:0046185) | 3.04904590 |
| 118 | cellular aldehyde metabolic process (GO:0006081) | 3.04177692 |
| 119 | positive regulation of hemostasis (GO:1900048) | 3.04125269 |
| 120 | positive regulation of blood coagulation (GO:0030194) | 3.04125269 |
| 121 | digestive system process (GO:0022600) | 3.02662938 |
| 122 | progesterone metabolic process (GO:0042448) | 3.00681076 |
| 123 | diterpenoid metabolic process (GO:0016101) | 3.00038254 |
| 124 | excretion (GO:0007588) | 2.99519373 |
| 125 | hydrogen peroxide catabolic process (GO:0042744) | 2.98239261 |
| 126 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.97510862 |
| 127 | nitric oxide biosynthetic process (GO:0006809) | 2.96631113 |
| 128 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.95475055 |
| 129 | activation of MAPKKK activity (GO:0000185) | 2.95467812 |
| 130 | positive regulation of coagulation (GO:0050820) | 2.94324425 |
| 131 | cellular glucuronidation (GO:0052695) | 2.93061865 |
| 132 | cyclooxygenase pathway (GO:0019371) | 2.92915617 |
| 133 | regulation of pseudopodium assembly (GO:0031272) | 2.92808020 |
| 134 | multicellular organismal metabolic process (GO:0044236) | 2.92017516 |
| 135 | icosanoid biosynthetic process (GO:0046456) | 2.91368871 |
| 136 | fatty acid derivative biosynthetic process (GO:1901570) | 2.91368871 |
| 137 | endothelial cell migration (GO:0043542) | 2.91157297 |
| 138 | epithelial structure maintenance (GO:0010669) | 2.91112894 |
| 139 | uronic acid metabolic process (GO:0006063) | 2.90867717 |
| 140 | glucuronate metabolic process (GO:0019585) | 2.90867717 |
| 141 | transepithelial transport (GO:0070633) | 2.90430547 |
| 142 | positive regulation of respiratory burst (GO:0060267) | 2.88600454 |
| 143 | mucosal immune response (GO:0002385) | 2.86424915 |
| 144 | NADH metabolic process (GO:0006734) | 2.86119706 |
| 145 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.86078475 |
| 146 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.85360403 |
| 147 | positive regulation of vesicle fusion (GO:0031340) | 2.85236527 |
| 148 | mitochondrial calcium ion transport (GO:0006851) | 2.84995778 |
| 149 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.84842715 |
| 150 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.84724849 |
| 151 | positive regulation of digestive system process (GO:0060456) | 2.82446612 |
| 152 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.80667763 |
| 153 | regulation of cGMP biosynthetic process (GO:0030826) | 2.79887564 |
| 154 | regulation of vitamin metabolic process (GO:0030656) | 2.79854440 |
| 155 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.79129735 |
| 156 | cellular copper ion homeostasis (GO:0006878) | 2.78772464 |
| 157 | intestinal absorption (GO:0050892) | 2.77164536 |
| 158 | organ or tissue specific immune response (GO:0002251) | 2.74856914 |
| 159 | bile acid and bile salt transport (GO:0015721) | 2.74625495 |
| 160 | long-chain fatty acid transport (GO:0015909) | 2.73860891 |
| 161 | valine metabolic process (GO:0006573) | 2.73651805 |
| 162 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.73023789 |
| 163 | positive regulation of steroid metabolic process (GO:0045940) | 2.72672110 |
| 164 | hepatocyte apoptotic process (GO:0097284) | 2.72251326 |
| 165 | glutathione metabolic process (GO:0006749) | 2.72211497 |
| 166 | innate immune response in mucosa (GO:0002227) | 2.66768656 |
| 167 | regulation of hormone biosynthetic process (GO:0046885) | 2.66422221 |
| 168 | terpenoid metabolic process (GO:0006721) | 2.66017358 |
| 169 | phototransduction, visible light (GO:0007603) | 2.62745193 |
| 170 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.60319909 |
| 171 | extracellular matrix disassembly (GO:0022617) | 2.54238846 |
| 172 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.53691578 |
| 173 | fatty acid derivative metabolic process (GO:1901568) | 2.53080289 |
| 174 | icosanoid metabolic process (GO:0006690) | 2.53080289 |
| 175 | negative regulation of hormone metabolic process (GO:0032351) | 2.44570001 |
| 176 | digestion (GO:0007586) | 16.8354832 |
| 177 | cobalamin metabolic process (GO:0009235) | 16.4303275 |
| 178 | ethanol oxidation (GO:0006069) | 13.0340506 |
| 179 | transcytosis (GO:0045056) | 10.9111249 |
| 180 | ethanol metabolic process (GO:0006067) | 10.2255113 |
| 181 | primary alcohol catabolic process (GO:0034310) | 10.2102466 |
| 182 | regulation of phospholipase A2 activity (GO:0032429) | 10.1283715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 7.20741545 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.90665643 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 5.21360241 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.75544989 |
| 5 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 3.28694789 |
| 6 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.05767115 |
| 7 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.03280279 |
| 8 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.03280279 |
| 9 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.03280279 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.01952895 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.88106090 |
| 12 | EGR1_19032775_ChIP-ChIP_M12_Human | 2.86278123 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.80409211 |
| 14 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.72051817 |
| 15 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.71588920 |
| 16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.60544587 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.44867217 |
| 18 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.35304815 |
| 19 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.28473811 |
| 20 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.27323343 |
| 21 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.25640964 |
| 22 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.10252421 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.09105709 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.06075546 |
| 25 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.05910920 |
| 26 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.03523044 |
| 27 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.03181712 |
| 28 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.94304063 |
| 29 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.84777589 |
| 30 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.84204808 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.80761212 |
| 32 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.80636190 |
| 33 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.77886456 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.76806782 |
| 35 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.74611958 |
| 36 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.69614561 |
| 37 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.67643326 |
| 38 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.67617737 |
| 39 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.64854481 |
| 40 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.62955503 |
| 41 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.62488999 |
| 42 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.62383117 |
| 43 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.61217858 |
| 44 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.61217858 |
| 45 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.61155398 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.60922045 |
| 47 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.55891923 |
| 48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50532670 |
| 49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49718705 |
| 50 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.48755788 |
| 51 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.48461622 |
| 52 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.47947699 |
| 53 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.47613206 |
| 54 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.47543083 |
| 55 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.46180569 |
| 56 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.45121896 |
| 57 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.45121896 |
| 58 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42047574 |
| 59 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40298140 |
| 60 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37585880 |
| 61 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.37182036 |
| 62 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.36299659 |
| 63 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.36184223 |
| 64 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.35904021 |
| 65 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33671556 |
| 66 | NFYA_21822215_ChIP-Seq_K562_Human | 1.31777752 |
| 67 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.31765391 |
| 68 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.31122377 |
| 69 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.30299125 |
| 70 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28710866 |
| 71 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.28147860 |
| 72 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.27510867 |
| 73 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.26969151 |
| 74 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.26040919 |
| 75 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.20616715 |
| 76 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.19289475 |
| 77 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19062896 |
| 78 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.18725221 |
| 79 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 1.17730994 |
| 80 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.17285175 |
| 81 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.14880475 |
| 82 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.10873689 |
| 83 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.10587105 |
| 84 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 1.08815658 |
| 85 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08569490 |
| 86 | NFYB_21822215_ChIP-Seq_K562_Human | 1.07727957 |
| 87 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.07531655 |
| 88 | SA1_27219007_Chip-Seq_Bcells_Human | 1.07268972 |
| 89 | RXR_22108803_ChIP-Seq_LS180_Human | 1.07046107 |
| 90 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.06629044 |
| 91 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06508711 |
| 92 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.05909995 |
| 93 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.05819662 |
| 94 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.04806199 |
| 95 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03959322 |
| 96 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.00903147 |
| 97 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00716604 |
| 98 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.00219408 |
| 99 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00094473 |
| 100 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.99620445 |
| 101 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.96848229 |
| 102 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.96448803 |
| 103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95805894 |
| 104 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.95798023 |
| 105 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.95332477 |
| 106 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.94413357 |
| 107 | P300_27268052_Chip-Seq_Bcells_Human | 0.94077814 |
| 108 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93132630 |
| 109 | ERA_21632823_ChIP-Seq_H3396_Human | 0.92341520 |
| 110 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92085409 |
| 111 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91170201 |
| 112 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.90185897 |
| 113 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.90034700 |
| 114 | CBP_21632823_ChIP-Seq_H3396_Human | 0.89343086 |
| 115 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.88858340 |
| 116 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.88087700 |
| 117 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.87150916 |
| 118 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85787769 |
| 119 | AR_20517297_ChIP-Seq_VCAP_Human | 0.85348331 |
| 120 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.85147691 |
| 121 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84446858 |
| 122 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.83412458 |
| 123 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.82006291 |
| 124 | TBL1_22424771_ChIP-Seq_293T_Human | 0.81984478 |
| 125 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.80876690 |
| 126 | CJUN_26792858_Chip-Seq_BT549_Human | 0.79562655 |
| 127 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.78851447 |
| 128 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78006843 |
| 129 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.77570889 |
| 130 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.77276047 |
| 131 | ATF3_27146783_Chip-Seq_COLON_Human | 0.76860847 |
| 132 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.76380387 |
| 133 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.75943447 |
| 134 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.75096639 |
| 135 | GATA2_19941826_ChIP-Seq_K562_Human | 0.74803384 |
| 136 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.74431625 |
| 137 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.74032235 |
| 138 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.73978885 |
| 139 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.73688351 |
| 140 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.73416826 |
| 141 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.73318697 |
| 142 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.72495530 |
| 143 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.72134091 |
| 144 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.72088281 |
| 145 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.71582656 |
| 146 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.71552633 |
| 147 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.70492530 |
| 148 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.70000929 |
| 149 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.69464092 |
| 150 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.65928087 |
| 151 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.64406673 |
| 152 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.64077056 |
| 153 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.63611310 |
| 154 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.62815861 |
| 155 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.62409190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003868_abnormal_feces_composition | 8.32124608 |
| 2 | MP0008875_abnormal_xenobiotic_pharmacok | 6.37614995 |
| 3 | MP0010030_abnormal_orbit_morphology | 3.95093809 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.92696410 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.76111725 |
| 6 | MP0001346_abnormal_lacrimal_gland | 3.63643366 |
| 7 | MP0004264_abnormal_extraembryonic_tissu | 3.56840362 |
| 8 | MP0002254_reproductive_system_inflammat | 3.32668732 |
| 9 | MP0002877_abnormal_melanocyte_morpholog | 2.99536015 |
| 10 | MP0005248_abnormal_Harderian_gland | 2.97931804 |
| 11 | MP0004019_abnormal_vitamin_homeostasis | 2.83599256 |
| 12 | MP0003959_abnormal_lean_body | 2.79410854 |
| 13 | MP0000537_abnormal_urethra_morphology | 2.72503851 |
| 14 | MP0005220_abnormal_exocrine_pancreas | 2.63353150 |
| 15 | MP0005083_abnormal_biliary_tract | 2.61646743 |
| 16 | MP0002132_abnormal_respiratory_system | 2.35939136 |
| 17 | MP0005360_urolithiasis | 2.31887970 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 2.30653310 |
| 19 | MP0003186_abnormal_redox_activity | 2.25287518 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.23836881 |
| 21 | MP0005085_abnormal_gallbladder_physiolo | 2.19338090 |
| 22 | MP0002909_abnormal_adrenal_gland | 2.18792804 |
| 23 | MP0000566_synostosis | 2.09747947 |
| 24 | MP0005365_abnormal_bile_salt | 2.09592475 |
| 25 | MP0010352_gastrointestinal_tract_polyps | 2.09291031 |
| 26 | MP0008789_abnormal_olfactory_epithelium | 2.08143477 |
| 27 | MP0004043_abnormal_pH_regulation | 2.05526251 |
| 28 | MP0003566_abnormal_cell_adhesion | 1.95303303 |
| 29 | MP0003183_abnormal_peptide_metabolism | 1.92413725 |
| 30 | MP0000678_abnormal_parathyroid_gland | 1.88938543 |
| 31 | MP0010678_abnormal_skin_adnexa | 1.88233046 |
| 32 | MP0010368_abnormal_lymphatic_system | 1.79993804 |
| 33 | MP0000762_abnormal_tongue_morphology | 1.78915743 |
| 34 | MP0002277_abnormal_respiratory_mucosa | 1.75355933 |
| 35 | MP0000467_abnormal_esophagus_morphology | 1.71956438 |
| 36 | MP0005408_hypopigmentation | 1.71059109 |
| 37 | MP0010386_abnormal_urinary_bladder | 1.71023637 |
| 38 | MP0005448_abnormal_energy_balance | 1.70181737 |
| 39 | MP0009840_abnormal_foam_cell | 1.66237283 |
| 40 | MP0002098_abnormal_vibrissa_morphology | 1.64865341 |
| 41 | MP0006054_spinal_hemorrhage | 1.62097181 |
| 42 | MP0000383_abnormal_hair_follicle | 1.54751947 |
| 43 | MP0001958_emphysema | 1.52967121 |
| 44 | MP0000613_abnormal_salivary_gland | 1.50108034 |
| 45 | MP0002693_abnormal_pancreas_physiology | 1.49538452 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.46976967 |
| 47 | MP0003828_pulmonary_edema | 1.42085454 |
| 48 | MP0010329_abnormal_lipoprotein_level | 1.37118938 |
| 49 | MP0002796_impaired_skin_barrier | 1.34530510 |
| 50 | MP0003300_gastrointestinal_ulcer | 1.31537962 |
| 51 | MP0003453_abnormal_keratinocyte_physiol | 1.22270627 |
| 52 | MP0005164_abnormal_response_to | 1.20588584 |
| 53 | MP0000579_abnormal_nail_morphology | 1.16700809 |
| 54 | MP0003724_increased_susceptibility_to | 1.16270748 |
| 55 | MP0009379_abnormal_foot_pigmentation | 1.15716594 |
| 56 | MP0004883_abnormal_blood_vessel | 1.15241959 |
| 57 | MP0001849_ear_inflammation | 1.15069201 |
| 58 | MP0001873_stomach_inflammation | 1.12156143 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.08639139 |
| 60 | MP0009764_decreased_sensitivity_to | 1.07775591 |
| 61 | MP0005332_abnormal_amino_acid | 1.05065325 |
| 62 | MP0005452_abnormal_adipose_tissue | 1.04048395 |
| 63 | MP0002234_abnormal_pharynx_morphology | 1.04016495 |
| 64 | MP0009053_abnormal_anal_canal | 1.03947677 |
| 65 | MP0005394_taste/olfaction_phenotype | 1.03323437 |
| 66 | MP0005499_abnormal_olfactory_system | 1.03323437 |
| 67 | MP0009643_abnormal_urine_homeostasis | 0.99609090 |
| 68 | MP0003866_abnormal_defecation | 0.99539349 |
| 69 | MP0005084_abnormal_gallbladder_morpholo | 0.97225527 |
| 70 | MP0001663_abnormal_digestive_system | 0.96988160 |
| 71 | MP0002060_abnormal_skin_morphology | 0.96074491 |
| 72 | MP0002133_abnormal_respiratory_system | 0.94573127 |
| 73 | MP0005388_respiratory_system_phenotype | 0.94573127 |
| 74 | MP0002078_abnormal_glucose_homeostasis | 0.93304383 |
| 75 | MP0004782_abnormal_surfactant_physiolog | 0.91793538 |
| 76 | MP0003953_abnormal_hormone_level | 0.89939732 |
| 77 | MP0005165_increased_susceptibility_to | 0.89877209 |
| 78 | MP0005334_abnormal_fat_pad | 0.88760908 |
| 79 | MP0000490_abnormal_crypts_of | 0.87220765 |
| 80 | MP0003879_abnormal_hair_cell | 0.86173437 |
| 81 | MP0003329_amyloid_beta_deposits | 0.85187619 |
| 82 | MP0001845_abnormal_inflammatory_respons | 0.84027410 |
| 83 | MP0001756_abnormal_urination | 0.83941691 |
| 84 | MP0001216_abnormal_epidermal_layer | 0.83289537 |
| 85 | MP0001501_abnormal_sleep_pattern | 0.83048404 |
| 86 | MP0001915_intracranial_hemorrhage | 0.82864723 |
| 87 | MP0003252_abnormal_bile_duct | 0.82090625 |
| 88 | MP0000462_abnormal_digestive_system | 0.81417381 |
| 89 | MP0000470_abnormal_stomach_morphology | 0.80625178 |
| 90 | MP0005381_digestive/alimentary_phenotyp | 0.80252180 |
| 91 | MP0004147_increased_porphyrin_level | 0.79668151 |
| 92 | MP0000681_abnormal_thyroid_gland | 0.77825130 |
| 93 | MP0001664_abnormal_digestion | 0.77223132 |
| 94 | MP0003690_abnormal_glial_cell | 0.76169122 |
| 95 | MP0002876_abnormal_thyroid_physiology | 0.74903941 |
| 96 | MP0005166_decreased_susceptibility_to | 0.73879043 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 0.73428461 |
| 98 | MP0003705_abnormal_hypodermis_morpholog | 0.73186318 |
| 99 | MP0000477_abnormal_intestine_morphology | 0.72698985 |
| 100 | MP0001765_abnormal_ion_homeostasis | 0.71420298 |
| 101 | MP0002233_abnormal_nose_morphology | 0.70473682 |
| 102 | MP0000598_abnormal_liver_morphology | 0.69114021 |
| 103 | MP0003045_fibrosis | 0.69031158 |
| 104 | MP0003011_delayed_dark_adaptation | 0.67870754 |
| 105 | MP0002295_abnormal_pulmonary_circulatio | 0.67766693 |
| 106 | MP0005023_abnormal_wound_healing | 0.67520225 |
| 107 | MP0000377_abnormal_hair_follicle | 0.66854346 |
| 108 | MP0009785_altered_susceptibility_to | 0.66132374 |
| 109 | MP0002118_abnormal_lipid_homeostasis | 0.66044363 |
| 110 | MP0005636_abnormal_mineral_homeostasis | 0.65123776 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.65047790 |
| 112 | MP0002138_abnormal_hepatobiliary_system | 0.64781795 |
| 113 | MP0000627_abnormal_mammary_gland | 0.64461934 |
| 114 | MP0003075_altered_response_to | 0.64136887 |
| 115 | MP0000538_abnormal_urinary_bladder | 0.62865713 |
| 116 | MP0003195_calcinosis | 0.61280778 |
| 117 | MP0000609_abnormal_liver_physiology | 0.60941731 |
| 118 | MP0008004_abnormal_stomach_pH | 0.60839457 |
| 119 | MP0009780_abnormal_chondrocyte_physiolo | 0.59197501 |
| 120 | MP0002970_abnormal_white_adipose | 0.58269927 |
| 121 | MP0004858_abnormal_nervous_system | 0.57104066 |
| 122 | MP0003436_decreased_susceptibility_to | 0.55863579 |
| 123 | MP0005376_homeostasis/metabolism_phenot | 0.55347353 |
| 124 | MP0010771_integument_phenotype | 0.55007540 |
| 125 | MP0000049_abnormal_middle_ear | 0.53821375 |
| 126 | MP0004947_skin_inflammation | 0.53659371 |
| 127 | MP0009642_abnormal_blood_homeostasis | 0.53465816 |
| 128 | MP0005409_darkened_coat_color | 0.52861310 |
| 129 | MP0004185_abnormal_adipocyte_glucose | 0.52592650 |
| 130 | MP0001502_abnormal_circadian_rhythm | 0.49212477 |
| 131 | MP0008469_abnormal_protein_level | 0.48091553 |
| 132 | MP0001944_abnormal_pancreas_morphology | 0.46555148 |
| 133 | MP0002089_abnormal_postnatal_growth/wei | 0.43568607 |
| 134 | MP0008872_abnormal_physiological_respon | 0.42302637 |
| 135 | MP0001485_abnormal_pinna_reflex | 0.39252808 |
| 136 | MP0003283_abnormal_digestive_organ | 0.38922524 |
| 137 | MP0001764_abnormal_homeostasis | 0.38859392 |
| 138 | MP0003718_maternal_effect | 0.38217895 |
| 139 | MP0005058_abnormal_lysosome_morphology | 0.36640456 |
| 140 | MP0003943_abnormal_hepatobiliary_system | 0.35124425 |
| 141 | MP0001731_abnormal_postnatal_growth | 0.34173570 |
| 142 | MP0004484_altered_response_of | 0.34014838 |
| 143 | MP0005410_abnormal_fertilization | 0.32690750 |
| 144 | MP0000367_abnormal_coat/_hair | 0.32328102 |
| 145 | MP0002822_catalepsy | 0.31869039 |
| 146 | MP0005451_abnormal_body_composition | 0.30997472 |
| 147 | MP0002166_altered_tumor_susceptibility | 0.30285131 |
| 148 | MP0000858_altered_metastatic_potential | 0.29310052 |
| 149 | MP0005387_immune_system_phenotype | 0.28173527 |
| 150 | MP0001790_abnormal_immune_system | 0.28173527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperactive renin-angiotensin system (HP:0000841) | 8.06768327 |
| 2 | Pancreatitis (HP:0001733) | 6.42752836 |
| 3 | Right ventricular cardiomyopathy (HP:0011663) | 5.81953243 |
| 4 | Renal salt wasting (HP:0000127) | 5.37358168 |
| 5 | Synostosis involving the elbow (HP:0003938) | 5.20664977 |
| 6 | Humeroradial synostosis (HP:0003041) | 5.20664977 |
| 7 | Abnormality of proline metabolism (HP:0010907) | 5.00770851 |
| 8 | Hydroxyprolinuria (HP:0003080) | 5.00770851 |
| 9 | Onycholysis (HP:0001806) | 4.69293332 |
| 10 | Increased circulating renin level (HP:0000848) | 4.50542386 |
| 11 | Malnutrition (HP:0004395) | 4.36288842 |
| 12 | Abnormality of chloride homeostasis (HP:0011422) | 4.26087005 |
| 13 | Hyperaldosteronism (HP:0000859) | 4.19410291 |
| 14 | Bronchomalacia (HP:0002780) | 4.15473983 |
| 15 | Abnormality of the pleura (HP:0002103) | 4.11802857 |
| 16 | Gout (HP:0001997) | 3.88235958 |
| 17 | Abnormality of renin-angiotensin system (HP:0000847) | 3.72445351 |
| 18 | Ulnar bowing (HP:0003031) | 3.58391615 |
| 19 | Hypokalemic alkalosis (HP:0001949) | 3.57541827 |
| 20 | Stenosis of the external auditory canal (HP:0000402) | 3.54355913 |
| 21 | Labial hypoplasia (HP:0000066) | 3.37739486 |
| 22 | Chronic bronchitis (HP:0004469) | 3.33682184 |
| 23 | Stomach cancer (HP:0012126) | 3.31783342 |
| 24 | Large eyes (HP:0001090) | 3.27384687 |
| 25 | Milia (HP:0001056) | 3.22571032 |
| 26 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.20582737 |
| 27 | Distal lower limb muscle weakness (HP:0009053) | 3.19902993 |
| 28 | Tetraparesis (HP:0002273) | 3.14177507 |
| 29 | Metabolic alkalosis (HP:0200114) | 3.10989090 |
| 30 | Hypoplastic female external genitalia (HP:0012815) | 3.08598118 |
| 31 | Tetany (HP:0001281) | 3.06160950 |
| 32 | Choroideremia (HP:0001139) | 3.06140587 |
| 33 | Micronodular cirrhosis (HP:0001413) | 3.05989855 |
| 34 | Abnormal platelet function (HP:0011869) | 3.05915127 |
| 35 | Impaired platelet aggregation (HP:0003540) | 3.05915127 |
| 36 | Abnormal pancreas size (HP:0012094) | 3.00312586 |
| 37 | Alopecia of scalp (HP:0002293) | 2.94748587 |
| 38 | Lip pit (HP:0100267) | 2.91956179 |
| 39 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.91714216 |
| 40 | Syncope (HP:0001279) | 2.90945368 |
| 41 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.89182357 |
| 42 | Esophageal varix (HP:0002040) | 2.89161380 |
| 43 | Abnormality of urine glucose concentration (HP:0011016) | 2.88599890 |
| 44 | Glycosuria (HP:0003076) | 2.88599890 |
| 45 | Ileus (HP:0002595) | 2.88512188 |
| 46 | Polycythemia (HP:0001901) | 2.88495077 |
| 47 | Fragile skin (HP:0001030) | 2.87191359 |
| 48 | Hypotension (HP:0002615) | 2.85007747 |
| 49 | Fragile nails (HP:0001808) | 2.80421889 |
| 50 | Abnormality of renal excretion (HP:0011036) | 2.79113885 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.78909466 |
| 52 | Abnormality of vitamin B metabolism (HP:0004340) | 2.76478646 |
| 53 | Tubulointerstitial nephritis (HP:0001970) | 2.72379698 |
| 54 | Tubulointerstitial fibrosis (HP:0005576) | 2.70092772 |
| 55 | Abnormality of the labia (HP:0000058) | 2.69048852 |
| 56 | Woolly hair (HP:0002224) | 2.68616911 |
| 57 | Abnormal blistering of the skin (HP:0008066) | 2.67910626 |
| 58 | Esophageal atresia (HP:0002032) | 2.65339564 |
| 59 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.63932417 |
| 60 | Palpitations (HP:0001962) | 2.52482944 |
| 61 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.51474963 |
| 62 | Pustule (HP:0200039) | 2.48885117 |
| 63 | Split foot (HP:0001839) | 2.45544553 |
| 64 | Congenital sensorineural hearing impairment (HP:0008527) | 2.42303912 |
| 65 | Atrophic scars (HP:0001075) | 2.41026921 |
| 66 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.40622115 |
| 67 | Aplasia of the phalanges of the hand (HP:0009802) | 2.40622115 |
| 68 | Aplasia involving bones of the extremities (HP:0009825) | 2.40622115 |
| 69 | Proximal tubulopathy (HP:0000114) | 2.39279566 |
| 70 | Bifid scrotum (HP:0000048) | 2.37132752 |
| 71 | Abnormality of vitamin metabolism (HP:0100508) | 2.36881308 |
| 72 | Bowed forearm bones (HP:0003956) | 2.36139032 |
| 73 | Bowing of the arm (HP:0006488) | 2.36139032 |
| 74 | Glomerulonephritis (HP:0000099) | 2.36002766 |
| 75 | Hypoplasia of dental enamel (HP:0006297) | 2.34545803 |
| 76 | Adrenal overactivity (HP:0002717) | 2.33591552 |
| 77 | Vaginal fistula (HP:0004320) | 2.33161121 |
| 78 | Hypomagnesemia (HP:0002917) | 2.31787350 |
| 79 | Abnormal hemoglobin (HP:0011902) | 2.30724894 |
| 80 | Short nail (HP:0001799) | 2.30311334 |
| 81 | Interstitial pulmonary disease (HP:0006530) | 2.30008208 |
| 82 | Abnormal drinking behavior (HP:0030082) | 2.28572497 |
| 83 | Polydipsia (HP:0001959) | 2.28572497 |
| 84 | Tubular atrophy (HP:0000092) | 2.25499210 |
| 85 | Choanal stenosis (HP:0000452) | 2.23628484 |
| 86 | Dehydration (HP:0001944) | 2.21194686 |
| 87 | Reduced antithrombin III activity (HP:0001976) | 2.21130037 |
| 88 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.20362819 |
| 89 | Plantar hyperkeratosis (HP:0007556) | 2.20096704 |
| 90 | Anal atresia (HP:0002023) | 2.16879316 |
| 91 | Abnormality of magnesium homeostasis (HP:0004921) | 2.15209335 |
| 92 | Hypercalciuria (HP:0002150) | 2.13852722 |
| 93 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.13422832 |
| 94 | Abnormal sex determination (HP:0012244) | 2.12452736 |
| 95 | Sex reversal (HP:0012245) | 2.12452736 |
| 96 | Vascular calcification (HP:0004934) | 2.10533942 |
| 97 | Pili torti (HP:0003777) | 2.07212320 |
| 98 | Glomerulosclerosis (HP:0000096) | 2.06426478 |
| 99 | Hyperammonemia (HP:0001987) | 2.05978355 |
| 100 | Ventricular arrhythmia (HP:0004308) | 2.04066955 |
| 101 | Increased purine levels (HP:0004368) | 2.03203857 |
| 102 | Hyperuricemia (HP:0002149) | 2.03203857 |
| 103 | Popliteal pterygium (HP:0009756) | 2.02483593 |
| 104 | Chronic diarrhea (HP:0002028) | 2.01838386 |
| 105 | Steatorrhea (HP:0002570) | 17.8186860 |
| 106 | Fat malabsorption (HP:0002630) | 14.4760815 |
| 107 | Exocrine pancreatic insufficiency (HP:0001738) | 10.6881352 |
| 108 | Hypoproteinemia (HP:0003075) | 10.1266357 |
| 109 | Osteomalacia (HP:0002749) | 1.99509825 |
| 110 | Potter facies (HP:0002009) | 1.99296547 |
| 111 | Facial shape deformation (HP:0011334) | 1.99296547 |
| 112 | Abdominal pain (HP:0002027) | 1.98397528 |
| 113 | Nasal polyposis (HP:0100582) | 1.97632973 |
| 114 | Hyperphosphatemia (HP:0002905) | 1.97405759 |
| 115 | Ventricular fibrillation (HP:0001663) | 1.96836723 |
| 116 | Complement deficiency (HP:0004431) | 1.95873936 |
| 117 | Chronic otitis media (HP:0000389) | 1.95745579 |
| 118 | Pigmentary retinal degeneration (HP:0001146) | 1.95610691 |
| 119 | Nausea (HP:0002018) | 1.95401609 |
| 120 | Villous atrophy (HP:0011473) | 1.93985444 |
| 121 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.93985444 |
| 122 | Curly hair (HP:0002212) | 1.93468178 |
| 123 | Scanning speech (HP:0002168) | 1.93376436 |
| 124 | Pterygium (HP:0001059) | 1.89709237 |
| 125 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.89067429 |
| 126 | Orchitis (HP:0100796) | 1.88901030 |
| 127 | Abnormal biliary tract morphology (HP:0012440) | 1.88833240 |
| 128 | Chondrocalcinosis (HP:0000934) | 1.88235651 |
| 129 | Paraparesis (HP:0002385) | 1.87445985 |
| 130 | Type I transferrin isoform profile (HP:0003642) | 1.87019163 |
| 131 | Cardiovascular calcification (HP:0011915) | 1.86709163 |
| 132 | Subacute progressive viral hepatitis (HP:0006572) | 1.85745490 |
| 133 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.85608615 |
| 134 | Decreased circulating renin level (HP:0003351) | 1.84741465 |
| 135 | Alkalosis (HP:0001948) | 1.83996771 |
| 136 | Femoral bowing (HP:0002980) | 1.82166285 |
| 137 | Bronchiectasis (HP:0002110) | 1.81021879 |
| 138 | Abnormality of purine metabolism (HP:0004352) | 1.79896622 |
| 139 | Rectal prolapse (HP:0002035) | 1.79649895 |
| 140 | Hypobetalipoproteinemia (HP:0003563) | 1.79234372 |
| 141 | Hypoplastic labia majora (HP:0000059) | 1.78598535 |
| 142 | Abnormality of complement system (HP:0005339) | 1.76668725 |
| 143 | Nephritis (HP:0000123) | 1.76181609 |
| 144 | Xanthomatosis (HP:0000991) | 1.74161794 |
| 145 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.70217110 |
| 146 | Dicarboxylic aciduria (HP:0003215) | 1.70217110 |
| 147 | Metabolic acidosis (HP:0001942) | 1.67069791 |
| 148 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.65951766 |
| 149 | Abdominal distention (HP:0003270) | 1.57848025 |
| 150 | Renal tubular acidosis (HP:0001947) | 1.57311016 |
| 151 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.57073873 |
| 152 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.57073873 |
| 153 | Abnormal protein glycosylation (HP:0012346) | 1.57073873 |
| 154 | Abnormal glycosylation (HP:0012345) | 1.57073873 |
| 155 | Megaloblastic anemia (HP:0001889) | 1.56930967 |
| 156 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.56890102 |
| 157 | Lower limb hyperreflexia (HP:0002395) | 1.54964412 |
| 158 | Hyperphosphaturia (HP:0003109) | 1.53048386 |
| 159 | Widely patent fontanelles and sutures (HP:0004492) | 1.52212194 |
| 160 | Hypophosphatemia (HP:0002148) | 1.46715145 |
| 161 | Male infertility (HP:0003251) | 1.46419055 |
| 162 | Late onset (HP:0003584) | 1.43413046 |
| 163 | Abnormality of nucleobase metabolism (HP:0010932) | 1.42587620 |
| 164 | Abnormality of the intrinsic pathway (HP:0010989) | 1.42230352 |
| 165 | Increased CSF protein (HP:0002922) | 1.39559083 |
| 166 | Abnormality of the nasal septum (HP:0000419) | 1.38915023 |
| 167 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.38080334 |
| 168 | Nephrolithiasis (HP:0000787) | 1.37978174 |
| 169 | Large for gestational age (HP:0001520) | 1.36965904 |
| 170 | Abnormality of methionine metabolism (HP:0010901) | 1.35109854 |
| 171 | Abnormal tarsal ossification (HP:0008369) | 1.34899634 |
| 172 | Hypoalbuminemia (HP:0003073) | 1.34279793 |
| 173 | Abnormal albumin level (HP:0012116) | 1.34279793 |
| 174 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.34153537 |
| 175 | Axonal loss (HP:0003447) | 1.33411300 |
| 176 | Abnormal urine phosphate concentration (HP:0012599) | 1.33262624 |
| 177 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.33023361 |
| 178 | Abnormality of glycine metabolism (HP:0010895) | 1.33023361 |
| 179 | Ketosis (HP:0001946) | 1.32481564 |
| 180 | Goiter (HP:0000853) | 1.32129258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 5.10984203 |
| 2 | EIF2AK3 | 3.86109456 |
| 3 | ERBB3 | 3.68721378 |
| 4 | MST1R | 3.60872837 |
| 5 | EPHA2 | 3.46304960 |
| 6 | EPHA3 | 3.25580717 |
| 7 | MAP3K2 | 3.25380130 |
| 8 | ACVR1B | 3.15518591 |
| 9 | EPHB2 | 2.97580940 |
| 10 | FRK | 2.96116308 |
| 11 | NME1 | 2.93555537 |
| 12 | RPS6KB2 | 2.79719513 |
| 13 | DAPK2 | 2.74588598 |
| 14 | TRPM7 | 2.62886575 |
| 15 | EPHB1 | 2.62355188 |
| 16 | MAP3K3 | 2.37650345 |
| 17 | FER | 2.32763312 |
| 18 | TAOK3 | 2.27379728 |
| 19 | GRK1 | 2.15502513 |
| 20 | MAP2K2 | 2.10921783 |
| 21 | LMTK2 | 1.83905238 |
| 22 | ERN1 | 1.76175701 |
| 23 | MAPKAPK3 | 1.69456017 |
| 24 | STK10 | 1.57869841 |
| 25 | ERBB2 | 1.48177935 |
| 26 | SGK2 | 1.42956545 |
| 27 | TBK1 | 1.42102126 |
| 28 | MYLK | 1.41694845 |
| 29 | SGK3 | 1.38694138 |
| 30 | PDK2 | 1.37415893 |
| 31 | OXSR1 | 1.31091023 |
| 32 | FGFR4 | 1.30945179 |
| 33 | LATS1 | 1.24477146 |
| 34 | INSRR | 1.22197564 |
| 35 | MAP2K1 | 1.21829048 |
| 36 | SGK223 | 1.21749452 |
| 37 | SGK494 | 1.21749452 |
| 38 | NEK6 | 1.21120309 |
| 39 | RIPK1 | 1.21023458 |
| 40 | LRRK2 | 1.20727514 |
| 41 | CDK6 | 1.17810655 |
| 42 | STK39 | 1.13205624 |
| 43 | MAPK15 | 1.13033387 |
| 44 | STK24 | 1.12938718 |
| 45 | HIPK2 | 1.09442863 |
| 46 | FGFR2 | 1.07845977 |
| 47 | NLK | 1.07659559 |
| 48 | PRKD3 | 1.06033617 |
| 49 | PTK6 | 1.05272375 |
| 50 | PBK | 1.03894569 |
| 51 | PTK2 | 1.00712838 |
| 52 | BMPR1B | 1.00037314 |
| 53 | TAOK1 | 0.98947201 |
| 54 | TEC | 0.97287476 |
| 55 | PIM2 | 0.95879205 |
| 56 | ZAP70 | 0.92207052 |
| 57 | EIF2AK1 | 0.90916483 |
| 58 | STK16 | 0.90635087 |
| 59 | BCR | 0.83883309 |
| 60 | WNK4 | 0.83433668 |
| 61 | PDGFRB | 0.83387631 |
| 62 | PINK1 | 0.82934209 |
| 63 | ALK | 0.82750003 |
| 64 | PRKG2 | 0.82587272 |
| 65 | MAP3K1 | 0.79853169 |
| 66 | TESK1 | 0.78323499 |
| 67 | IRAK2 | 0.78080476 |
| 68 | GRK6 | 0.77678502 |
| 69 | MET | 0.76079104 |
| 70 | KSR1 | 0.75653270 |
| 71 | NTRK3 | 0.75455503 |
| 72 | PIK3CA | 0.75153318 |
| 73 | MAP3K12 | 0.72330684 |
| 74 | CDK19 | 0.64699584 |
| 75 | FGFR3 | 0.61802358 |
| 76 | STK3 | 0.60888441 |
| 77 | PRKCI | 0.60096576 |
| 78 | PDK1 | 0.59505213 |
| 79 | IRAK1 | 0.58490670 |
| 80 | TGFBR1 | 0.58108930 |
| 81 | MATK | 0.56076046 |
| 82 | STK38L | 0.56050915 |
| 83 | MAP3K5 | 0.54539724 |
| 84 | NEK9 | 0.53300806 |
| 85 | MELK | 0.53058636 |
| 86 | TYRO3 | 0.52401033 |
| 87 | ITK | 0.51644068 |
| 88 | MAP2K6 | 0.51587230 |
| 89 | PAK4 | 0.50093975 |
| 90 | PRKCD | 0.49264519 |
| 91 | MAPK7 | 0.48596559 |
| 92 | MAP3K11 | 0.48152313 |
| 93 | PRKD1 | 0.44600762 |
| 94 | PDPK1 | 0.44371450 |
| 95 | SRC | 0.43415109 |
| 96 | IKBKE | 0.42924712 |
| 97 | TAOK2 | 0.41967420 |
| 98 | PRKCE | 0.41825300 |
| 99 | DDR2 | 0.41633169 |
| 100 | TIE1 | 0.38891741 |
| 101 | STK38 | 0.38178441 |
| 102 | SIK1 | 0.36735945 |
| 103 | PRKAA2 | 0.35652981 |
| 104 | BMX | 0.34980675 |
| 105 | DAPK1 | 0.34875906 |
| 106 | IGF1R | 0.34808798 |
| 107 | STK4 | 0.34563127 |
| 108 | PRKCQ | 0.34108907 |
| 109 | TYK2 | 0.33937713 |
| 110 | MAP3K9 | 0.33339267 |
| 111 | PRKACG | 0.32963611 |
| 112 | KSR2 | 0.32236257 |
| 113 | MAP3K7 | 0.32099640 |
| 114 | ROCK1 | 0.31872134 |
| 115 | CAMK2D | 0.31750098 |
| 116 | PAK3 | 0.31556774 |
| 117 | RPS6KA5 | 0.31346964 |
| 118 | JAK2 | 0.30149780 |
| 119 | PASK | 0.30076993 |
| 120 | TGFBR2 | 0.29622320 |
| 121 | DAPK3 | 0.28296594 |
| 122 | SCYL2 | 0.26965952 |
| 123 | FYN | 0.26880894 |
| 124 | PRKCA | 0.25745655 |
| 125 | JAK1 | 0.25378066 |
| 126 | MAPK12 | 0.25229148 |
| 127 | CDC42BPA | 0.24645192 |
| 128 | TNIK | 0.24212691 |
| 129 | ERBB4 | 0.23551546 |
| 130 | HCK | 0.23077609 |
| 131 | ROCK2 | 0.23004799 |
| 132 | MAP3K10 | 0.22694566 |
| 133 | WNK1 | 0.22577169 |
| 134 | FGFR1 | 0.21910437 |
| 135 | CAMK2B | 0.21396430 |
| 136 | MAP3K14 | 0.21391901 |
| 137 | CDK8 | 0.20968634 |
| 138 | MAPKAPK5 | 0.20736537 |
| 139 | MAPKAPK2 | 0.19793260 |
| 140 | BCKDK | 0.19186443 |
| 141 | CSNK1A1 | 0.18561292 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 6.01679168 |
| 2 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 5.76187933 |
| 3 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 5.00966266 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.21285963 |
| 5 | Glutathione metabolism_Homo sapiens_hsa00480 | 3.55970250 |
| 6 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.94019094 |
| 7 | Histidine metabolism_Homo sapiens_hsa00340 | 2.58477631 |
| 8 | Retinol metabolism_Homo sapiens_hsa00830 | 2.55129116 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.46629267 |
| 10 | Sulfur relay system_Homo sapiens_hsa04122 | 2.42874938 |
| 11 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.35283962 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.16464701 |
| 13 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.13902333 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.81811305 |
| 15 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72485989 |
| 16 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.70207477 |
| 17 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.51147201 |
| 18 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.50707576 |
| 19 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.35203267 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.35059028 |
| 21 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.33988983 |
| 22 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.32420136 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.17901002 |
| 24 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.13303624 |
| 25 | Mineral absorption_Homo sapiens_hsa04978 | 1.07360775 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.05832000 |
| 27 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.03205320 |
| 28 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.00294948 |
| 29 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.00106813 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.00103899 |
| 31 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87624367 |
| 32 | Galactose metabolism_Homo sapiens_hsa00052 | 0.86726178 |
| 33 | Tight junction_Homo sapiens_hsa04530 | 0.85402813 |
| 34 | Bladder cancer_Homo sapiens_hsa05219 | 0.75683312 |
| 35 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.71798917 |
| 36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.71570768 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.71461597 |
| 38 | Adherens junction_Homo sapiens_hsa04520 | 0.67518822 |
| 39 | Salivary secretion_Homo sapiens_hsa04970 | 0.66911425 |
| 40 | Leishmaniasis_Homo sapiens_hsa05140 | 0.66485179 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.66316610 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66057448 |
| 43 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65987887 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.65966369 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.62949633 |
| 46 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.61498294 |
| 47 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.60117996 |
| 48 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.57132575 |
| 49 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54424670 |
| 50 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.52783816 |
| 51 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.50240902 |
| 52 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.50183673 |
| 53 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50084454 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.49863047 |
| 55 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48830289 |
| 56 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.47919903 |
| 57 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47424490 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.47091434 |
| 59 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.43015273 |
| 60 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41514269 |
| 61 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.41361141 |
| 62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.40216772 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39378070 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.38389276 |
| 65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.37738810 |
| 66 | Thyroid cancer_Homo sapiens_hsa05216 | 0.37348982 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.36730559 |
| 68 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.36590633 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.36031406 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35856380 |
| 71 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.34626914 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.34324334 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.33713603 |
| 74 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.33540956 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32958307 |
| 76 | Circadian rhythm_Homo sapiens_hsa04710 | 0.31130258 |
| 77 | Asthma_Homo sapiens_hsa05310 | 0.29921297 |
| 78 | Peroxisome_Homo sapiens_hsa04146 | 0.29433741 |
| 79 | Salmonella infection_Homo sapiens_hsa05132 | 0.29236793 |
| 80 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.28697776 |
| 81 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.28695038 |
| 82 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.26920606 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.26128033 |
| 84 | Carbon metabolism_Homo sapiens_hsa01200 | 0.25822337 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23951785 |
| 86 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.23415859 |
| 87 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.23156791 |
| 88 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.22520042 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.22448420 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | 0.21959863 |
| 91 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.21095861 |
| 92 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.20905417 |
| 93 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.20333449 |
| 94 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.20054435 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.19710564 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.19571470 |
| 97 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.19489634 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.18853989 |
| 99 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.18794738 |
| 100 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.18597156 |
| 101 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.17602107 |
| 102 | ABC transporters_Homo sapiens_hsa02010 | 0.17182351 |
| 103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.16918755 |
| 104 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.14835369 |
| 105 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.13020163 |
| 106 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.11967110 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.11859795 |
| 108 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.11134415 |
| 109 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.09678353 |
| 110 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.09343041 |
| 111 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.08947343 |
| 112 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.08562356 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.08383691 |
| 114 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.08232726 |
| 115 | Influenza A_Homo sapiens_hsa05164 | 0.08216880 |
| 116 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.07197218 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.07067046 |
| 118 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.06721198 |
| 119 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.05837316 |
| 120 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.05669966 |
| 121 | Metabolic pathways_Homo sapiens_hsa01100 | 0.05178899 |
| 122 | Protein export_Homo sapiens_hsa03060 | 0.03885980 |
| 123 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.03088305 |
| 124 | Allograft rejection_Homo sapiens_hsa05330 | 0.01089740 |
| 125 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.00626698 |
| 126 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | -0.0897282 |
| 127 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0762285 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0405575 |
| 129 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | -0.0297740 |
| 130 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | -0.0203395 |
| 131 | Graft-versus-host disease_Homo sapiens_hsa05332 | -0.0054682 |
| 132 | Insulin secretion_Homo sapiens_hsa04911 | -0.0042795 |

